Harvard Apparatus Regenerative Technology

Bringing the world's first regenerated organ transplants to patients

Investor Relations

About Us

HART is a biotechnology company developing bioengineered organs for life-threatening conditions. Our central focus continues to be the development of bioengineered organs for life-threatening conditions. HART has built a dedicated internal team of materials scientists, engineers and biologists who are working with our external collaborators to bring our products to the patients who need them as quickly as possible.

Stock Information

Featured Financial Releases